EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline

Alexandra M Barnett, Elizabeth M McNair, Lamar Dawkins, Jian Zou, Viktoriya D Nikolova, Sheryl S Moy, Greg T Sutherland, Julia Stevens, Meagan Colie, Kemi Katemboh, Hope Kellner, Katherine Ho und 4 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Alexandra M Barnett und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Sterol Esterase, Cognitive Dysfunction, Brain. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Child Health and Human Development, NIA NIH HHS, NIAAA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Underlying drivers of Alzheimer's disease (AD) remain unknown, though several distinct risk exposures share a common pathological progression. METHODS The cellular and molecular consequences of two common midlife AD risk factors—heavy alcohol use and obesity—were compared to uncover novel mediators that contribute to AD. RESULTS Both AD risk exposures reduced levels of neuronal lysosomal acid lipase (LAL), which contributed to AD pathology and cognitive decline. LAL was lost with age in mice and humans with greater losses in AD and inverse associations with amyloid β (Aβ). LAL loss preceded Aβ pathology in AD mice, and neuronal LAL knockdown enhanced pathology and cognitive decline. In human AD brain, robust reductions in LAL protein were found with indications of a transcriptional mechanism. LAL gene therapy reduced pathology and improved cognition and affect in vivo. DISCUSSION LAL loss is an age‐related contributor to AD pathology that can be targeted therapeutically. Highlights The loss of lysosomal acid lipase (LAL) contributes to Alzheimer's disease progression. LAL is lost is normal aging and Alzheimer's disease risk exposures. LAL loss is greater in human Alzheimer's brain and predicts the extent of pathology. LAL gene therapy blunts Alzheimer’ pathology, improving cognition and mood with age.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSterol EsteraseCognitive DysfunctionBrainHumansAnimalsMiceFemaleMaleMice, TransgenicAmyloid beta-PeptidesDisease Models, AnimalAgedObesity

Stichwörter der Autor:innen

Alzheimer's diseaseagingalcohollipidlysosomal acid lipaselysosomeobesity

Substanzen

Sterol EsteraseAmyloid beta-PeptidesLIPA protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Department of Psychiatry, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
  • Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill, Carrboro, North Carolina, USA.
  • New South Wales Brain Tissue Resource Centre and Charles Perkins Centre, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

Förderung

  • National Institute of Child Health and Human Development
  • NIA NIH HHS
  • NIAAA NIH HHS
  • NICHD NIH HHS
  • National Institute on Aging
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Barnett, A. M., McNair, E. M., Dawkins, L., Zou, J., Nikolova, V. D., Moy, S. S., Sutherland, G. T., Stevens, J., Colie, M., Katemboh, K., Kellner, H., Ho, K., Damian, C., DeCastro, S., Vetreno, R. P., & Coleman, L. G. (2025). Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70486

Vancouver

Barnett AM, McNair EM, Dawkins L, Zou J, Nikolova VD, Moy SS, et al. Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70486

BibTeX
@article{Barnett2025,
  author = {Barnett, Alexandra M and McNair, Elizabeth M and Dawkins, Lamar and Zou, Jian and Nikolova, Viktoriya D and Moy, Sheryl S and Sutherland, Greg T and Stevens, Julia and Colie, Meagan and Katemboh, Kemi and Kellner, Hope and Ho, Katherine and Damian, Corina and DeCastro, Sagan and Vetreno, Ryan P and Coleman, Leon G},
  title = {Loss of lysosomal acid lipase contributes to Alzheimer's disease pathology and cognitive decline},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70486}
}
Kostenlos starten →